Glenmark Receives FDA Approval to Market Generic Montelukast in the US

by Kathy Jones on  November 29, 2011 at 7:57 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Glenmark Pharmaceuticals revealed that it will be marketing generic Montelukast Sodium tablets in the United States from August next year after it received approval by the US Food and Drug Administration to provide the drugs for treating asthma and seasonal allergies.
 Glenmark Receives FDA Approval to Market Generic Montelukast in the US
Glenmark Receives FDA Approval to Market Generic Montelukast in the US

Glenmark said that it will be manufacturing the tablets after Merck's patent expires in August next year.

The tablets are generic version of the Singulair tablets being sold by Merck with the 10mg strength tablets generating more than $3.2 billion in sales in the last 12 months.

The company also said that it has 73 products available in the US market. Furthermore, it also has over 40 abbreviated new drug applications (ANDAs) that have been submitted to the FDA for approval.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive